DekaBank Deutsche Girozentrale’s Medifast MED Stock Holding History

DekaBank Deutsche Girozentrale’s Portfolio MED Stock Details MED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-7,932	Closed	-$536K	–	1484
2023 Q4	$536K	Sell	7,932 -6,567	-45%	-$457K	﹤0.01%	1021
2023 Q3	$1.11M	Hold	14,499	–	–	﹤0.01%	857
2023 Q2	$1.33M	Sell	14,499 -200	-1%	-$17.8K	﹤0.01%	832
2023 Q1	$1.43M	Buy	14,699 +1,894	+15%	+$210K	﹤0.01%	797
2022 Q4	$1.45M	Buy	+12,805	New	+$1.49M	﹤0.01%	793
2022 Q2	–	Sell	-18,500	Closed	-$3.16M	–	1404
2022 Q1	$3.16M	Sell	18,500 -37,000	-67%	-$6.98M	0.01%	653
2021 Q4	$11.7M	Buy	+55,500	New	+$11.5M	0.03%	389
2020 Q2	–	Sell	-722	Closed	-$45K	–	1069
2020 Q1	$45K	Hold	722	–	–	﹤0.01%	1005
2019 Q4	$77K	Sell	722 -178	-20%	-$17.2K	﹤0.01%	1062
2019 Q3	$91K	Hold	900	–	–	﹤0.01%	920
2019 Q2	$116K	Buy	+900	New	+$125K	﹤0.01%	1072

Other funds holding MED

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

DekaBank Deutsche Girozentrale's MED Position: Q1 2024 in Review

DekaBank Deutsche Girozentrale sold out of Medifast (MED) in Q1 2024, closing a stake of 7,932 shares — an estimated $536K sold.

DekaBank Deutsche Girozentrale first reported a position in MED in Q2 2019 and held it in 11 quarters. The position peaked at $11.7M in Q4 2021. 186 funds tracked by Wall St. Rank hold MED as of Q1 2024.

DekaBank Deutsche Girozentrale reported no remaining Medifast position as of Q1 2024 after selling out during the quarter.
DekaBank Deutsche Girozentrale sold 7,932 Medifast shares in Q1 2024, an estimated $536K.
DekaBank Deutsche Girozentrale first reported a position in Medifast in Q2 2019 and held it in 11 quarters.
DekaBank Deutsche Girozentrale's Medifast position peaked at $11.7M in Q4 2021.
186 funds tracked by Wall St. Rank held Medifast as of Q1 2024.

Based on DekaBank Deutsche Girozentrale's 13F filing for Q1 2024, filed 24 Apr 2024.